Ther-biotic Interface 120 VegCaps

Biofilm and Enzyme Formulation

Biofilm consists of microorganisms encased within a self-produced matrix of exopolysaccharides and exoproteins that adheres to interfaces and resists dislodgement. Microorganisms in biofilms are highly resistant to antimicrobials, including antibiotics and bacteriocins produced by probiotics. Ther-Biotic InterFase is a unique enzyme formulation that is specially designed to disrupt the biofilm matrix that embeds gastrointestinal organisms.

Enzymes Included

• Ther-Biotic InterFase
• Enzymes in Ther-Biotic InterFase
• are selected for their ability to lyse the extracellular polymers commonly found in biofilm as well as degrade bacterial and yeast cell wall structures.
• The enzyme blend in Ther-Biotic InterFase was developed using in vitro testing of antibiofilm activity and was found to have significant antibiofilm activity resulting in meaningful degradation of undesirable biofilm communities.
• Ther-Biotic InterFase is intended for use in conjunction with efforts to support normal gastrointestinal function and microbiota.
• As an adjunct, it is best combined with the use of a high-strength, broad-spectrum, multispecies probiotic formulation and a prebiotic to encourage the formation of healthy intestinal microbial biofilm communities.
• Serving Size 1 Capsule
• Amount Per Capsule — % Daily Value
• Proprietary Enzyme Blend — 425 mg
• Providing the following active enzymes:
• Polysaccharide Specific Enzymes
• Glucoamylase (with isomaltase side chain activity)
• Chitosanase
• Cellulase
• Hemicellulase (xylanase) and Pectinase Complex
• Beta-Glucanase
• Protein and Peptide Specific Enzymes
• Protease/Peptidase Complex with endopeptidase, exopeptidase, and DPP-IV activity
• Other Enzymes
• Lysozyme (from egg white)
• Serratia peptididase (from Serratia marcescens) (enteric-coated) (Peptizyme SP)
• Daily value not established